A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background and Aim. The efficacy of supplementation treatment with two multispecies probiotic formulates on subjects diagnosed with IBS-C and the assessment of their gut microbiota were investigated.Methods. A randomized, double-blind, three-arm parallel group trial was carried out on 150 IBS-C subjects divided into three groups (F_1, F_2, and F_3). Each group received a daily oral administration of probiotic mixtures (for 60 days) F_1 or F_2 or placebo F_3, respectively. Fecal microbiological analyses were performed by species-specific qPCR to assess the different amount of probiotics.Results. The percentage of responders for each symptom was higher in the probiotic groups when compared to placebo group during the treatment period (t60) and was maintained quite similar during the follow-up period (t90). Fecal analysis demonstrated that probiotics of the formulations increased during the times of treatment only in fecal DNA from subjects treated with F_1 and F_2 and not with F_3, and the same level was maintained during the follow-up period.Conclusions. Multispecies probiotic supplementations are effective in IBS-C subjects and induce a different assessment in the composition of intestinal microbiota. This clinical study is registered with the clinical study registration number ISRCTN15032219.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study intervened with a mixture of two probiotics at the same dose, which could lead to bias that affected the evidence for the results [53].”
From Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials (2022) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 1×
“Fresh fecal samples were homogenized by vortex mixing of the fecal mass and separated into aliquots to be stored at − 80 ∘ C until the analysis using DNA-based method quantitative PCR. Stool types were classified according to Bristol scale [23].”
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005) · Cell · doi:10.1016/j.cell.2005.05.007 · Cited by 2,910 · cited 1×
“The microbial community resides in the gut of the host establishing a mutually beneficial relationship and modulating, through its metabolic activities, the host’s health status [2, 3].”
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
The fundamental basis of inflammatory bowel disease
Strober, W., Fuss, I., & Mannon, P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30587 · Cited by 1,319 · cited 1×
“Oral administration of appropriate probiotic strains may therefore be beneficial to health and in particular with respect to IBS.”
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761 · cited 1×
“Life Measure for Persons with IBS [22].”
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728 · cited 1×
“Although a great number of data deriving from literature [16–18, 30] indicate Thus, the clinical improvement of this study may be associated with the maintenance (species-specific) of the compositional stability of the intestinal microbiota from probiotics consumption and with their positive…”
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699 · cited 1×
“Indeed, it is known that the level of bifidobacteria and lactobacilli species is lower in IBS patients compared to healthy persons [28, 29] and several studies show that the supplementation of them, or mixtures including species of these genera, is effective in alleviating symptoms of IBS.”
Research works printed but not linked: 2
- 2011, Annali Italiani di Chirurgia, 82, 361
- 2013, PloS ONE, 8
Cited by
Gut Microbiota and Chronic Constipation: A Review and Update
Ohkusa, T., Koido, S., Nishikawa, Y., & Sato, N. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00019 · Cited by 354
The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
Serra, J., Pohl, D., Azpiroz, F., Chiarioni, G., Ducrotté, P., Gourcerol, G., Hungin, A. P. S., Layer, P., Mendive, J., Pfeifer, J., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13762 · Cited by 244
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Guarner, F., Sanders, M. E., Szajewska, H., Cohen, H., Eliakim, R., Herrera-deGuise, C., Karakan, T., Merenstein, D., Piscoya, A., Ramakrishna, B., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002002 · Cited by 209
Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
Dale, H. F., Rasmussen, S. H., Asiller, Ö. Ö., & Lied, G. A. (2019) · Nutrients · doi:10.3390/nu11092048 · Cited by 166
“Four studies included participants with only one subtypes of IBS; three studies only included participants with IBS-D [29,31,32]; and one study only included participants with IBS-C [35].”
InfluentialEfficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Li, B., Li, L., Deng, H., Guo, J., Shu, H., & Zhang, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00332 · Cited by 109
“There were two (Lorenzo-Zuniga et al., 2014; Mezzasalma et al., 2016) of these RCTs examining two different dose groups and one (Whorwell et al., 2006) examining three different dose groups.”
BackgroundInfluentialMarasco, G., Cirota, G. G., Rossini, B., Lungaro, L., Biase, A. R. D., Colecchia, A., Volta, U., GIORGIO, R. D., Festi, D., & Caio, G. (2020) · Nutrients · doi:10.3390/nu12092674 · Cited by 101
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome
Harris, L. A., & Baffy, N. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1383819 · Cited by 83
Di Rosa, C., Altomare, A., Terrigno, V., Carbone, F., Tack, J., Cicala, M., & Guarino, M. (2023) · Nutrients · doi:10.3390/nu15071647 · Cited by 78
Layer, P., Andresen, V., Allescher, H., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel-Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 76
Preston, K., Krumian, R., Hattner, J., de Montigny, D., Stewart, M., & Gaddam, S. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0105 · Cited by 70
Effects of therapeutic probiotics on modulation of microRNAs
Davoodvandi, A., Marzban, H., Goleij, P., Sahebkar, A., Morshedi, K., Rezaei, S., Mahjoubin‐Tehran, M., Tarrahimofrad, H., Hamblin, M. R., & Mirzaei, H. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00668-w · Cited by 72
Darb Emamie, A., Rajabpour, M., Ghanavati, R., Asadolahi, P., Farzi, S., Sobouti, B., & Darbandi, A. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14907 · Cited by 57
Biopolymer‐Based Multilayer Microparticles for Probiotic Delivery to Colon
Talebian, S., Schofield, T., Valtchev, P., Schindeler, A., Kavanagh, J. M., Adil, Q., & Dehghani, F. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102487 · Cited by 55
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review
Chlebicz-Wójcik, A., & Śliżewska, K. (2021) · Biomolecules · doi:10.3390/biom11081154 · Cited by 60
“…tablet/d Maltodextrin 1 tablet/d 90 days Attenuation of symptoms (bloating, vomiting, stool frequency, abdominal pain, diarrhea) Improved quality of life Mezzasalma et al. (2016) [121] The randomized, double-blind, placebocontrolled study Rome III 157 males/females18–65 y IBS-C Product 1: 5 × 109…”
MethodResultInfluentialDe Giani, A., Sandionigi, A., Zampolli, J., Michelotti, A., Tursi, F., Labra, M., & Di Gennaro, P. (2022) · Microorganisms · doi:10.3390/microorganisms10061256 · Cited by 46
Self-citationBotelho, P. B., Ferreira, M. V. R., Araújo, A. D. M., Mendes, M. M., & Nakano, E. Y. (2020) · Nutrition · doi:10.1016/j.nut.2020.110890 · Cited by 52
“[31] conducted a randomized, double-blind, three-arm parallel group trial with 150 patients with irritable bowel syndrome associated with constipation divided into three groups (F_1, F_2, and F_3).”
MethodMichelotti, A., Cestone, E., Ponti, I. D., Giardina, S., Pisati, M., Spartà, E., & Tursi, F. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.4019 · Cited by 55
Self-citationProbiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role
Kumar, L. S., Pugalenthi, L. S., Ahmad, M., Reddy, S., Barkhane, Z., & Elmadi, J. (2022) · Cureus · doi:10.7759/cureus.24240 · Cited by 78
“It concluded that the supplementation of multispecies probiotics is effective in the IBS-C subjects [60].”
BackgroundXie, P., Luo, M., Deng, X., Fan, J., & Xiong, L. (2023) · Nutrients · doi:10.3390/nu15173856 · Cited by 50
Shang, X., E, F.-F., Guo, K.-L., Li, Y.-F., Zhao, H.-L., Wang, Y., Chen, N., Nian, T., Yang, C.-Q., Yang, K.-H., et al. (2022) · Nutrients · doi:10.3390/nu14122482 · Cited by 41
Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
Jia, L.-Q., Sun, J.-R., Kong, C.-F., Qu, X.-K., Deng, C., & Lou, Y.-N. (2020) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_384_19 · Cited by 40
“Mezzasalma et al.[28] (2016) Italy 157 (not reported) 18‐65 RomeIII, 100% IBS: C Combination one capsule containing L.”
BackgroundInfluentialProbiotics for management of functional abdominal pain disorders in children
Gordon, M. A., Wallace, C., Sinopoulou, V., & Akobeng, A. K. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012849.pub2 · Cited by 57
Corbitt, M., Campagnolo, N., Staines, D., & Marshall‐Gradisnik, S. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9397-8 · Cited by 39
Vodnar, D. C., Călinoiu, L. F., Mitrea, L., Precup, G., Bindea, M., Păcurar, A. M., Szabo, K., & Ștefănescu, B. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816397-9.00015-7 · Cited by 46
Ari, M. M., Teymouri, S., Fazlalian, T., Asadollahi, P., Afifirad, R., Sabaghan, M., Valizadeh, F., Ghanavati, R., & Darbandi, A. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24326 · Cited by 44
Microbiome restoration diet improves digestion, cognition and physical and emotional wellbeing
Lawrence, K., & Hyde, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179017 · Cited by 34
“Despite some inconsistency in study findings, orally administered probiotics have also been reported to help alleviate gastrointestinal symptoms in IBS [17,18].”
BackgroundResultInfluentialRetractedJeong, J., Ganesan, R., Jin, Y.-J., Park, H., Min, B. H., Jeong, M. K., Yoon, S. J., Choi, M., Choi, J., Moon, J. H., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1174968 · Cited by 40
A narrative review on the use of probiotics in several diseases. Evidence and perspectives
Campaniello, D., Bevilacqua, A., Speranza, B., Racioppo, A., Sinigaglia, M., & Corbo, M. R. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1209238 · Cited by 38
Ceccherini, C., Daniotti, S., Bearzi, C., & Re, I. (2022) · Nutrients · doi:10.3390/nu14132689 · Cited by 42
Min, U.-G., Jin, Y.-J., Jang, Y. J., Lim, J.-H., & Kim, B. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1302093 · Cited by 37
How can probiotic improve irritable bowel syndrome symptoms?
Horvat, I. B., Gobin, I., Kresović, A., & Hauser, G. (2021) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v13.i9.923 · Cited by 40
Wang, W., Xin, H., Fang, X., Dou, H., Liu, F., Huang, D., Han, S., Fei, G., Zhu, L., Zha, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175276 · Cited by 32
Malfa, P., Brambilla, L., Giardina, S., Masciarelli, M., Squarzanti, D. F., Carlomagno, F., & Méloni, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021323 · Cited by 35
Kim, M. G., Jo, K., Cho, K., Park, S. S., Suh, H. J., & Hong, K. (2021) · Food Science of Animal Resources · doi:10.5851/kosfa.2021.e17 · Cited by 27
Hou, Y., Dong, L., Lu, X., Shi, H., Xu, B., Zhong, W., Ma, L., Wang, S., Yang, C., He, X., et al. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07588-4 · Cited by 29
Mullish, B. H., Michael, D. R., Dabcheva, M., Webberley, T. S., Coates, N., John, D. A., Wang, D., Luo, Y., Plummer, S. F., & Marchesi, J. R. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14751 · Cited by 38
“36,37 There are known to be psychological and cognitive burdens associated with IBS 38 with anxiety/depression affecting over a third of those with IBS 39 and cognitive impairments have also been observed.”
Gai, Z., Dong, Y., Xu, F., Zhang, J., Yang, Y., & Wang, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1105694 · Cited by 27
“Probiotics can improve the clinical symptoms of patients with gastrointestinal diseases and regulate the gut microbiota (5, 6).”
BackgroundSandionigi, A., Giani, A. D., Tursi, F., Michelotti, A., Cestone, E., Giardina, S., Zampolli, J., & Gennaro, P. D. (2022) · BioMed Research International · doi:10.1155/2022/3860896 · Cited by 29
“The most remarkable result was that the positive variations recorded after the treatment were still evident after the follow-up period, suggesting that probiotics may colonize, persist, and exert a long-term effect [36].”
Self-citationEffects of probiotics and its fermented milk on constipation: a systematic review
Yan, J., Wu, M., Zhao, W. K., Kwok, L. Y., & Zhang, W. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.024 · Cited by 24
Improved gastrointestinal health for irritable bowel syndrome with metagenome-guided interventions
Meydan, C., Afshinnekoo, E., Rickard, N., Daniels, G., Kunces, L. J., Hardy, T. M., Lili, L., Pesce, S., Jacobson, P., Mason, C. E., et al. (2020) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaa013 · Cited by 24
The significance of the gut microbiome in children with functional constipation
Kwiatkowska, M., & Krogulska, A. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/131215 · Cited by 22
Vicariotto, F., Malfa, P., Viciani, E., Dell'Atti, F., Squarzanti, D., Marcante, A., Castagnetti, A., Ponchia, R., Governini, L., & de Leo, V. (2024) · Nutrients · doi:10.3390/nu16030402 · Cited by 19
“While it provided valuable insights into short-term effects, a longer trial duration would offer a more comprehensive understanding of the treatment’s efficacy.”
BackgroundEffect of probiotics intake on constipation in children: an umbrella review
Dong, M., Wu, Y., Zhang, M., Chen, P., Zhang, Z., & Wang, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1218909 · Cited by 20
Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
Wang, Y., Zheng, F., Liu, S., & Luo, H. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/9759138 · Cited by 18
“Supplementation with Lactobacilli or Bifidobacteria not only reduces the intestinal mucosal inflammatory response in PI-IBS patients [69] but also significantly improves the symptoms of diarrhea and constipation [70].”
BackgroundThe efficacy of probiotics in the management of intra-oral halitosis: a systematic review
Tay, J. R. H., Ng, E., Lai, C. W. M., Lim, L. P., & Ong, M. M. A. (2022) · Clinical Oral Investigations · doi:10.1007/s00784-022-04522-w · Cited by 15
Potential Targets in Constipation Research: A Review
Ravichandiran, V., Arumugam, S., Bisht, P., Dagar, N., & Kumar, N. (2022) · Current Drug Targets · doi:10.2174/1389450124666221209123541 · Cited by 16
Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review
Ahlawat, G. M., & Singh, P. K. (2023) · Current Therapeutic Research · doi:10.1016/j.curtheres.2023.100721 · Cited by 13
“In this study, 22 the authors compared the gut microbiota of patients with IBS with that of a control group of individuals showing no symptoms of digestive distress, considering factors such as age and sex.”
BackgroundFunctional Abdominal Bloating and Gut Microbiota: An Update
Crucillà, S., Caldart, F., Michelon, M., Marasco, G., & Costantino, A. (2024) · Microorganisms · doi:10.3390/microorganisms12081669 · Cited by 15
“Probiotics and antibiotics have been the subject of investigation, with probiotics potentially modulating the gut microbiome to alleviate bloating, whereas antibiotics such as rifaximin may reduce bacterial gas production [29–33].”
BackgroundAll Properties of Infertility Microbiome in a Review Article
Elahi, Z., Mokhtaryan, M., Mahmoodi, S., Shahroodian, S., Darbandi, T., Ghasemi, F., Ghanavati, R., & Darbandi, A. (2025) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.25158 · Cited by 16
“Research indicates that multi-strain and/or multi-species probiotics may, in certain instances, be more efficacious than single-strain probiotics, as the various strains or species may synergistically enhance each other's benefits [218].”
Comprehensive evaluation of interventions: eight vital parameters
Zauszniewski, J. A., Bekhet, A. K., & Herbell, K. (2018) · Nurse Researcher · doi:10.7748/nr.2018.e1603 · Cited by 12
Borgonetti, V., Cocetta, V., Biagi, M., Carnevali, I., Governa, P., & Montopoli, M. (2020) · Minerva Pediatrics · doi:10.23736/s2724-5276.20.05765-5 · Cited by 16
Jandee, S., Chuensakul, S., & Maneerat, S. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00406-8 · Cited by 10
“acidophillus (575 bp, 55 °C, SYBR) F:5′-CAC TTC GGT GAT GAC GTT GG-3′ R: 5′-CGA TGC AGT TCC TCG GTT AAGC-3′ [19]”
BackgroundDey, K., & Sheth, M. K. (2023) · Food Production Processing and Nutrition · doi:10.1186/s43014-022-00117-w · Cited by 19
Lactic Acid Bacteria: Taxonomy, Characteristic Features, Physiology, and Diversity
Rama, G. R., Bücker, F., Salazar, M. M., Ray, S., & Granada, C. E. (2024) · Springer eBooks · doi:10.1007/978-981-97-3413-9_1 · Cited by 12
Iribarren, C., Maasfeh, L., Öhman, L., & Simrén, M. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.6 · Cited by 9
“…(Bonfrate et al., 2020; Yoon et al., 2014, 2015; Supplementary References: Mixtures) in certain IBS subtypes (Hod et al., 2018; Ki Cha et al., 2012; Mezzasalma et al., 2016) In addition, the response to the probiotic formulation may be predicted by faecal bacterial patterns at baseline (Hod et…”
BackgroundInfluentialJang, Y. J., Min, B., Lim, J. H., & Kim, B. (2023) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2303.03011 · Cited by 8
“An clinical study has shown that the administration of these strains alleviates IBS symptoms such as bloating, abdominal pain, constipation, abdominal cramps, and flatulence [14].”
The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome
Jach, M. E., Sajnaga, E., Bumbul, M., Serefko, A., Borowicz, K. K., Golczyk, H., Kieliszek, M., & Wiater, A. (2025) · Molecules · doi:10.3390/molecules30204130 · Cited by 9
“In contrast, Mezzasalma et al. [248] conducted a study involving three groups of IBS patients with predominant constipation, with two groups taking probiotic preparations and one receiving a placebo.”
Chang, Y. H., Choi, Y. J., Shin, C. M., Moon, J. S., Kim, T., Yoon, H., Park, Y. S., Kim, N., & Lee, D. H. (2024) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23036 · Cited by 9
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review
Lopes, C. M., Monteiro, C. S. D. J., Duarte, A. P., & dos Santos, J. L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216337 · Cited by 8
“…in the follow-up period and the chronicity that characterizes most gastrointestinal pathologies, including IBS, it would be pertinent that new trials had longer durations of treatments and follow-up after the product discontinuation, aiming to confirm their efficacy and safety for longer periods.”
BackgroundMethodInfluentialFinazzi, M., Bovio, F., Forcella, M. E., Lasagni, M., Fusi, P. A., & Gennaro, P. D. (2025) · Microorganisms · doi:10.3390/microorganisms13010192 · Cited by 6
“The species-specific primer sets utilized in this study are reported by De Giani et al. [17] and in Table S1 [26–31].”
Liu, L., Ni, X., Tian, T., Li, X., Li, F., Sun, M., Chen, J., Zhou, S., & Zhao, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037582 · Cited by 19
Nonpharmacologic options for treating irritable bowel syndrome
Kay, E., Hawramee, S., Pollani, S., & Mandel, E. D. (2019) · JAAPA · doi:10.1097/01.jaa.0000553384.82884.b8 · Cited by 5
Almabruk, B. A., Bajafar, A. A., Mohamed, A., Al-Zahrani, S. A., Albishi, N. M., Aljarwan, R. M., Aljaser, R. A., Alghamdi, L. I., Almutairi, T., Alsolami, A. S., et al. (2024) · Cureus · doi:10.7759/cureus.75954 · Cited by 4
Giani, A. D., Perillo, F., Baeri, A., Finazzi, M., Facciotti, F., & Gennaro, P. D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301822 · Cited by 3
Cocetta, V., Giacomini, I., Tinazzi, M., Berretta, M., Quagliariello, V., Maurea, N., Ragazzi, E., Carnevali, I., & Montopoli, M. (2023) · Minerva Pediatrics · doi:10.23736/s2724-5276.23.07128-8 · Cited by 8
Clinical assessment on the efficacy of a combined treatment targeting subjects with acne-prone skin
Carlomagno, F., Pesciaroli, C., Cestone, E., Ponti, I. D., Michelotti, A., & Tursi, F. (2022) · Our Dermatology Online · doi:10.7241/ourd.20223.1 · Cited by 7
Self-citationvan der Geest, A. M., Schukking, I., Brummer, R. J., Pieterse, H., van den Nieuwboer, M., van de Burgwal, L., & Larsen, O. F. A. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0124 · Cited by 4
Mezzasalma, V., Manfrini, E., Ferri, E., Sandionigi, A., Ferla, B. L., Schiano, I., Michelotti, A., Nobile, V., Labra, M., & Gennaro, P. D. (2019) · BioMed Research International · doi:10.1155/2019/9042956 · Cited by 3
Self-citationWang, Z., Chen, Y., Li, X., Li, L., Chen, B., Chen, M., & Zheng, H. (2025) · Quality of Life Research · doi:10.1007/s11136-025-03927-w · Cited by 2
Biotic therapies for irritable bowel syndrome: current interventions
Wodarczyk, G., Winte, M. F., Mastellone, D., Singh, T., DeSipio, J., & Phadtare, S. (2026) · Gastroenterology report · doi:10.1093/gastro/goag062 · Cited by 1
Disorders of intestinal transit
Hedayat, K. M., & Lapraz, J.-C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816964-3.00010-9 · Cited by 1
Ćosić, A., Islam, N., & Hromić‐Jahjefendić, A. (2023) · Periodicals of Engineering and Natural Sciences (PEN) · doi:10.21533/pen.v11i2.3438 · Cited by 1
Wie wirksam sind Probiotika bei Reizdarm, CED und C.-difficile-Infektionen?
Toader, J., & Erhardt, A. (2023) · Gastro-News · doi:10.1007/s15036-023-3240-0
Adjuvant nutraceuticals in the management of gastrointestinal diseases
Balio, B. G., Giro, R., & Roriz, M. (2023) · Acta Portuguesa de Nutrição · doi:10.21011/apn.2023.3210
Safabakhsh, M., Mohammadpour, M., Rohani, P., Ekbatani, M., Pourhadi, Z., Imani, H., & Shab‐Bidar, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-45936-w
“Likewise, probiotics improve the intestinal ecosystem by increasing the production of mucoprotein and reducing the adhesion of pathogenic bacteria 43 .”
Zhou, Z., Li, Y., Tu, Y., He, M., Liao, D., He, Z., 刘志仁, Li, B., 周祖刚, & 艾双春 (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761301
“…(Jin, 2014; Ford et al., 2018; Serra et al., 2020), low FODMAP diet (Domingo and Sánchez, 2020), fiber and probiotic supplementation (Isakov et al., 2013; Mezzasalma et al., 2016), and pharmacological therapy with osmotic laxatives, stimulant laxatives, and stool softeners (Sayuk et al., 2022).”
Role of the Gut Microbiome in Natural and Synthetic Drug Efficacy and Safety: A Narrative Review
Villoch-Rosado, R., Acosta, D., Morales-Santiago, L., González-Tardí, I. M., Medina-Rodríguez, O., Ríos, K., Agront-Medina, I., Alvarado-Andino, A. E., Báez-Rodríguez, L. A., Calderón-Nuñez, A., et al. (2026) · Applied Microbiology · doi:10.3390/applmicrobiol6100113
“…Consti-Biome and Sensi-Biome improve constipation-related symptoms, abdominal pain, urgency, and stool consistency while promoting favorable shifts in microbial composition, suggesting that individualized microbial interventions may complement conventional pharmacological treatments [60,192,193].”
Metadata
- Authors
- Mezzasalma, V., Manfrini, E., Ferri, E., Sandionigi, A., La Ferla, B., Schiano, I., Michelotti, A., Nobile, V., Labra, M., & Di Gennaro, P.
- Affiliations
- University of Milano-Bicocca (IT)
- Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, Italy
- Farcoderm Srl., Via Angelini 21, San Martino Siccomario, 27028 Pavia, Italy
- ORCID
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4993960
- OpenAlex
- W2510462781
- Cited by
- 81
- References
- 28
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 10 · 2023: 17 · 2022: 15 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 3 · 2017: 3
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2019-04-09)
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- Funders
- Probioplus4Food (30221122)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome with constipation, multispecies probiotics, probiotic supplementation, gut microbiota, fecal microbiota, symptom relief
- MeSH terms
- Adolescent, Adult, Aged, Constipation, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Dietary Supplements, Probiotics, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.